Systematic Review of Hospital Treatment Outcomes for Naturally Acquired and Bioterrorism-Related Anthrax, 1880-2018.
Marissa K PersonRachel CookJohn S BradleyNathaniel HupertWilliam A BowerKatherine HendricksPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Combination therapy appeared to be superior to monotherapy for inhalation anthrax without meningitis. For anthrax meningitis, neither monotherapy nor combination therapy were particularly effective; however, numbers were small. For localized cutaneous anthrax, monotherapy was sufficient. For B. anthracis exposures, PEPAbx was effective.